Inventor · disambiguated record
Hannah S. White
Also filed as: WHITE HANNAH · WHITE HANNAH S
14 granted patents·3 pending applications·75 citations·filing 2017–2025
92Inventor score
Top patents by PatentIndex Score
17 records- 0196US11960266B1Patient-specific medical devices and additive manufacturing processes for producing the sameRESTOR3D INC·Filed 2023·Granted Apr 16, 2024·8 cites·7 claims
- 0295US12168666B2Morphic forms of trilaciclib and methods of manufacture thereofG1 THERAPEUTICS INC·Filed 2021·Granted Dec 17, 2024·8 cites·27 claims
- 0395US10988479B1Morphic forms of trilaciclib and methods of manufacture thereofG1 THERAPEUTICS INC·Filed 2020·Granted Apr 27, 2021·15 cites·14 claims
- 0494US12139494B2Morphic forms of G1T38 and methods of manufacture thereofG1 THERAPEUTICS INC·Filed 2022·Granted Nov 12, 2024·3 cites·1 claims
- 0594US11708337B2Synthesis of 1,4-diazaspiro[5.5]undecan-3-oneG1 THERAPEUTICS INC·Filed 2021·Granted Jul 25, 2023·5 cites·26 claims
- 0693US12264135B2Synthesis of 1,4-diazaspiro[5.5]undecan-3-onePHARMACOSMOS HOLDING AS·Filed 2023·Granted Apr 1, 2025·3 cites·18 claims
- 0793US11261193B2Morphic forms of G1T38 and methods of manufacture thereofG1 THERAPEUTICS INC·Filed 2019·Granted Mar 1, 2022·5 cites·20 claims
- 0892US10865210B2Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-aminesG1 THERAPEUTICS INC·Filed 2018·Granted Dec 15, 2020·9 cites·37 claims
- 0992US10231969B2Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat RB-positive tumorsG1 THERAPEUTICS INC·Filed 2017·Granted Mar 19, 2019·12 cites·13 claims
- 1091US11629150B2Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-aminesG1 THERAPEUTICS INC·Filed 2020·Granted Apr 18, 2023·3 cites·5 claims
- 1191US11446295B2Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat Rb-positive tumorsG1 THERAPEUTICS INC·Filed 2019·Granted Sep 20, 2022·4 cites·6 claims
- 1286US2025101030A1Morphic forms of trilaciclib and methods of manufacture thereofPHARMACOSMOS HOLDING AS·Filed 2024·Application pending·0 cites
- 1381US12497404B2Morphic forms of trilaciclib and methods of manufacture thereofPHARMACOSMOS HOLDING AS·Filed 2025·Granted Dec 16, 2025·0 cites·11 claims
- 1481US12479855B2Morphic forms of trilaciclib and methods of manufacture thereofPHARMACOSMOS HOLDING AS·Filed 2025·Granted Nov 25, 2025·0 cites·13 claims
- 1580US12265373B1Patient-specific medical devices and additive manufacturing processes for producing the sameRESTOR3D INC·Filed 2024·Granted Apr 1, 2025·0 cites·18 claims
- 1677US2025304592A1Morphic forms of g1t38 and methods of manufacture thereofPHARMACOSMOS HOLDING AS·Filed 2024·Application pending·0 cites
- 1773US2023241059A1Anti-neoplastic combinations and dosing regimens using cdk4/6 inhibitor compounds to treat rb-positive tumorsG1 THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hannah S. White files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →